FDA Approves First-in-Class Oncolytic Virus Immunotherapy for the Treatment of Melanoma
October 27, 2015 FDA Approves First-in-Class Oncolytic Virus Immunotherapy for the Treatment of Melanoma MILWAUKEE, WISCONSIN – This week marks another advance in the fight…